The creation of a system for monitoring the progression of retinal pigmentary degeneration (retinitis pigmentosa – RP) depending on the mutation causing the disease, using neural networks, in a cohort of 200 patients with different modes of RP inheritance in the Polish population.

Pursuant to the study assumptions, 200 patients aged 8–60 suffering from rare eye diseases will be enrolled in the examination.

Eligibility criteria for participation in the project:

1. individuals aged 8–60,

2. individuals with health insurance,

3. individuals holding a referral from a primary care physician (PCP) to an ophthalmology clinic,

4. individuals voluntarily applying for the examination,

5. individuals residing in Poland,

6. individuals providing informed consent to participate in the study and to the processing of personal data in accordance with GDPR.

The following individuals are not eligible to participate in the project:

1. those who do not consent to participation in the study,

2. those who do not consent to the processing of personal data under GDPR.

Each participant will receive information containing detailed data on the purpose and principles of conducting the study, the expected therapeutic benefits, and any potential risks associated with participation.

As part of the project, the following three stages of research will be carried out:

• ophthalmological examination stage,

• genetic testing stage,

• algorithm development stage.